A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.

Abstract

BACKGROUND Serum CA125 (sCA125) was recently reported to be of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma (NHL). This report aims to investigate the prognostic value of a new serologic index combining sCA125 and LDH serum levels. PATIENTS AND METHODS One hundred thirty-seven patients were studied, sixty-three with… (More)

Topics

5 Figures and Tables

Cite this paper

@article{Benboubker2000ANS, title={A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.}, author={Lofti Benboubker and Chantal Valat and Claude Linassier and G{\'e}raldine Cartron and M. Delain and M Bout and Franck F{\'e}tissof and T Lefranq and Jean Pierre Lamagnere and Philippe Colombat}, journal={Annals of oncology : official journal of the European Society for Medical Oncology}, year={2000}, volume={11 11}, pages={1485-91} }